HEADER APOPTOSIS 16-FEB-19 6O0K TITLE CRYSTAL STRUCTURE OF BCL-2 WITH VENETOCLAX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BCL2-L-1,APOPTOSIS REGULATOR BCL-X; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2, BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS BCL-2, VENETOCLAX, COMPLEX, PROTEIN-PROTEIN INTERFACE INHIBITOR, FDA KEYWDS 2 APPROVED DRUG COMPLEX, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR R.W.BIRKINSHAW,C.S.LUO,P.M.COLMAN,P.E.CZABOTAR REVDAT 6 11-OCT-23 6O0K 1 COMPND HETNAM HETSYN REVDAT 5 11-DEC-19 6O0K 1 HETSYN REVDAT 4 20-NOV-19 6O0K 1 COMPND HETNAM FORMUL REVDAT 3 10-JUL-19 6O0K 1 COMPND SOURCE DBREF REVDAT 2 19-JUN-19 6O0K 1 JRNL REVDAT 1 22-MAY-19 6O0K 0 JRNL AUTH R.W.BIRKINSHAW,J.N.GONG,C.S.LUO,D.LIO,C.A.WHITE, JRNL AUTH 2 M.A.ANDERSON,P.BLOMBERY,G.LESSENE,I.J.MAJEWSKI,R.THIJSSEN, JRNL AUTH 3 A.W.ROBERTS,D.C.S.HUANG,P.M.COLMAN,P.E.CZABOTAR JRNL TITL STRUCTURES OF BCL-2 IN COMPLEX WITH VENETOCLAX REVEAL THE JRNL TITL 2 MOLECULAR BASIS OF RESISTANCE MUTATIONS. JRNL REF NAT COMMUN V. 10 2385 2019 JRNL REFN ESSN 2041-1723 JRNL PMID 31160589 JRNL DOI 10.1038/S41467-019-10363-1 REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 18463 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 905 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.6738 - 2.9436 1.00 3151 169 0.1616 0.1915 REMARK 3 2 2.9436 - 2.3364 1.00 3003 156 0.1568 0.2009 REMARK 3 3 2.3364 - 2.0411 1.00 2956 154 0.1400 0.1992 REMARK 3 4 2.0411 - 1.8545 1.00 2947 146 0.1541 0.2022 REMARK 3 5 1.8545 - 1.7215 1.00 2942 149 0.1843 0.2274 REMARK 3 6 1.7215 - 1.6200 0.88 2559 131 0.2181 0.2614 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.020 1466 REMARK 3 ANGLE : 1.512 1998 REMARK 3 CHIRALITY : 0.114 186 REMARK 3 PLANARITY : 0.010 322 REMARK 3 DIHEDRAL : 19.160 900 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 9 THROUGH 90 ) REMARK 3 ORIGIN FOR THE GROUP (A): 2.9883 -4.6853 -8.4132 REMARK 3 T TENSOR REMARK 3 T11: 0.1186 T22: 0.1163 REMARK 3 T33: 0.1227 T12: 0.0090 REMARK 3 T13: -0.0028 T23: 0.0052 REMARK 3 L TENSOR REMARK 3 L11: 3.0238 L22: 4.2763 REMARK 3 L33: 3.6595 L12: 0.4526 REMARK 3 L13: -0.0764 L23: 2.0573 REMARK 3 S TENSOR REMARK 3 S11: -0.0405 S12: -0.1932 S13: -0.1506 REMARK 3 S21: 0.2873 S22: 0.0573 S23: -0.1368 REMARK 3 S31: 0.2783 S32: 0.1838 S33: 0.0372 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 91 THROUGH 118 ) REMARK 3 ORIGIN FOR THE GROUP (A): -10.5218 -3.8155 -11.8456 REMARK 3 T TENSOR REMARK 3 T11: 0.1130 T22: 0.0866 REMARK 3 T33: 0.1444 T12: -0.0039 REMARK 3 T13: 0.0152 T23: -0.0162 REMARK 3 L TENSOR REMARK 3 L11: 4.0352 L22: 3.5322 REMARK 3 L33: 5.1602 L12: 0.5373 REMARK 3 L13: -0.0943 L23: 0.6600 REMARK 3 S TENSOR REMARK 3 S11: 0.0196 S12: 0.1460 S13: -0.1527 REMARK 3 S21: -0.1488 S22: 0.0469 S23: 0.1154 REMARK 3 S31: 0.2385 S32: 0.0319 S33: -0.1246 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 119 THROUGH 143 ) REMARK 3 ORIGIN FOR THE GROUP (A): -5.3828 8.7284 -20.3167 REMARK 3 T TENSOR REMARK 3 T11: 0.1527 T22: 0.0866 REMARK 3 T33: 0.1267 T12: 0.0162 REMARK 3 T13: 0.0012 T23: 0.0329 REMARK 3 L TENSOR REMARK 3 L11: 3.3062 L22: 3.3434 REMARK 3 L33: 4.4342 L12: -1.0961 REMARK 3 L13: -1.6612 L23: 0.9003 REMARK 3 S TENSOR REMARK 3 S11: 0.1138 S12: 0.4173 S13: 0.2060 REMARK 3 S21: -0.3757 S22: -0.0822 S23: -0.0662 REMARK 3 S31: -0.0388 S32: -0.1874 S33: 0.0807 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 144 THROUGH 203 ) REMARK 3 ORIGIN FOR THE GROUP (A): -2.5758 5.1764 -9.5150 REMARK 3 T TENSOR REMARK 3 T11: 0.1009 T22: 0.0870 REMARK 3 T33: 0.0884 T12: 0.0113 REMARK 3 T13: -0.0132 T23: -0.0020 REMARK 3 L TENSOR REMARK 3 L11: 2.3012 L22: 1.9597 REMARK 3 L33: 2.3084 L12: -0.5555 REMARK 3 L13: -1.4223 L23: 1.1554 REMARK 3 S TENSOR REMARK 3 S11: -0.0069 S12: -0.0821 S13: 0.0748 REMARK 3 S21: 0.0316 S22: 0.0345 S23: -0.0627 REMARK 3 S31: 0.0850 S32: 0.0664 S33: -0.0164 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6O0K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1000239797. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18474 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620 REMARK 200 RESOLUTION RANGE LOW (A) : 43.658 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4LVT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5% PEG4K, 40%PEG400, 0.1M MES PH 6.0, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.86250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.65800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.25300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.65800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.86250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 24.25300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 ALA A 4 REMARK 465 GLY A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 GLY A 8 REMARK 465 VAL A 77 REMARK 465 GLU A 78 REMARK 465 GLU A 79 REMARK 465 ASN A 80 REMARK 465 ARG A 81 REMARK 465 THR A 82 REMARK 465 GLU A 83 REMARK 465 ALA A 84 REMARK 465 PRO A 85 REMARK 465 GLU A 86 REMARK 465 GLY A 87 REMARK 465 THR A 88 REMARK 465 GLU A 89 REMARK 465 PRO A 204 REMARK 465 SER A 205 REMARK 465 MET A 206 REMARK 465 ARG A 207 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 35 CG OD1 OD2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LBM A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2PE A 302 DBREF 6O0K A 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 6O0K A 35 91 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 6O0K A 92 207 UNP P10415 BCL2_HUMAN 92 207 SEQRES 1 A 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 A 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 A 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 A 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 A 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 A 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 A 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 A 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 A 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 A 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 A 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG HET LBM A 301 122 HET 2PE A 302 28 HETNAM LBM 4-{4-[(4'-CHLORO-5,5-DIMETHYL[3,4,5,6-TETRAHYDRO[1,1'- HETNAM 2 LBM BIPHENYL]]-2-YL)METHYL]PIPERAZIN-1-YL}-N-[(3-NITRO-4- HETNAM 3 LBM {[(OXAN-4-YL )METHYL]AMINO}PHENYL)SULFONYL]-2-[(1H- HETNAM 4 LBM PYRROLO[2,3-B]PYRIDIN-5-YL)OXY]BENZAMIDE HETNAM 2PE NONAETHYLENE GLYCOL HETSYN LBM VENETOCLAX, 2-((1H-PYRROLO[2,3-B]PYRIDIN-5-YL)OXY)-4- HETSYN 2 LBM (4-((4'-CHLORO-5,5-DIMETHYL-3,4,5,6-TETRAHYDRO-[1,1'- HETSYN 3 LBM BIPHENYL]-2-YL)METHYL)PIPE RAZIN-1-YL)-N-((3-NITRO-4- HETSYN 4 LBM (((TETRAHYDRO-2H-PYRAN-4-YL)METHYL)AMINO)PHENYL) HETSYN 5 LBM SULFONYL)BENZAMIDE FORMUL 2 LBM C45 H50 CL N7 O7 S FORMUL 3 2PE C18 H38 O10 FORMUL 4 HOH *98(H2 O) HELIX 1 AA1 ASP A 10 ARG A 26 1 17 HELIX 2 AA2 TRP A 30 ASP A 34 5 5 HELIX 3 AA3 GLU A 91 TYR A 108 1 18 HELIX 4 AA4 TYR A 108 LEU A 119 1 12 HELIX 5 AA5 THR A 125 ARG A 139 1 15 HELIX 6 AA6 ASN A 143 ARG A 164 1 22 HELIX 7 AA7 SER A 167 HIS A 184 1 18 HELIX 8 AA8 LEU A 185 ASN A 192 1 8 HELIX 9 AA9 GLY A 193 GLY A 203 1 11 SITE 1 AC1 23 ARG A 12 ALA A 100 ASP A 103 PHE A 104 SITE 2 AC1 23 ARG A 107 TYR A 108 ASP A 111 MET A 115 SITE 3 AC1 23 LEU A 137 ASN A 143 TRP A 144 GLY A 145 SITE 4 AC1 23 VAL A 148 ALA A 149 GLU A 152 PHE A 153 SITE 5 AC1 23 PHE A 198 TYR A 202 2PE A 302 HOH A 403 SITE 6 AC1 23 HOH A 440 HOH A 441 HOH A 447 SITE 1 AC2 4 ARG A 12 TYR A 108 ASN A 172 LBM A 301 CRYST1 33.725 48.506 87.316 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029652 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020616 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011453 0.00000